The world’s highest-density Peptide Microarray.
Mining the ‘Ground Truth’ for biological interactions.
Unlike competitors who rely on public databases or slow phage display methods, GeneOn utilizes a proprietary lithography-based peptide synthesis technology.
We can synthesize and screen 200,000 unique peptides on a single slide. This allows us to map the entire interaction landscape of a target protein in a single experiment.
AI models trained on our physical chip data outperform those trained on noisy public databases. We feed AI with reality.
From 100 to 200,000 interactions. We can screen entire viral proteomes or huge antibody libraries overnight.
We pinpoint the exact binding residues (Epitope) at amino-acid resolution, crucial for antibody drug development.
Identify unknown binding partners for your target protein from a library of 20,000+ human proteins.
Determine exactly where an antibody binds. Essential for IP protection and mechanism study.
Analyze antibody profiles in patient serum to discover novel diagnostic biomarkers for cancer or autoimmune diseases.
ENGLISH
